Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Aclaris Therapeutics Charts.

Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Aclaris Therapeutics Charts.

Aclaris Therapeutics Inc News

Form S-3 - Registration statement under Securities Act of 1933
Thursday 27 February 2025 (2 days ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Thursday 27 February 2025 (2 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 27 February 2025 (2 days ago) • Edgar (US Regulatory)

Aclaris Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update
Thursday 27 February 2025 (2 days ago) • GlobeNewswire Inc.

New Publication Highlights Unique Properties of ATI-2138, a Potent and Selective Inhibitor of ITK and JAK3
Wednesday 12 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 4 February 2025 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 4 February 2025 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 4 February 2025 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 4 February 2025 (4 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 4 February 2025 (4 weeks ago) • Edgar (US Regulatory)

Aclaris Therapeutics Announces Formation of New Scientific Advisory Board
Thursday 30 January 2025 (4 weeks ago) • GlobeNewswire Inc.

Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Monday 6 January 2025 (2 months ago) • GlobeNewswire Inc.

More Aclaris Therapeutics Inc News Articles

Societe Generale Effekten

BNP Paribas Issuance

WisdomTree Commodity Sec...

Manz Automation Ag Npv

PRINTING SCIENCES

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions